Troy, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Conduct scientific reserch and investigations to advance the publics basic knowledge of cardiovascular diseases, pulmonary diseases and cancer and to develop treatments and cures for cardiovascular diseases, pulmonary
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2021 | 2020 | Change | |
|---|---|---|---|
| Revenue | N/A | N/A | N/A |
| Expenses | $47,786 | $9,357 | +4.1% |
| Net Income | N/A | $-9,357 | N/A |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Dr Lawrence S Zisman | President | 001.00 |
Officer
Director
Highest
|
$0 | $0 | $0 |
| Shreefal mehta | Director | 001.00 |
Director
|
$0 | $0 | $0 |
| Michael Lobsinger | Director | 000.25 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2021 | No data | $47,786 | $27,789 | No data |
| 2020 | No data | $9,357 | $75,511 | No data |
| 2019 | No data | $15,474 | $84,867 | No data |
| 2018 | $36,028 | $46,967 | $68,109 | $-10,939 |
Compare Rensselaer Center for Translational Research Inc with other nonprofits in New York and across the country.